DNAPrint Historical Cash Flow
| DNAG Stock | USD 0.00001 0.00 0.00% |
Analysis of DNAPrint Genomics cash flow over time is an excellent tool to project DNAPrint Genomics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 3.3 M or Change To Liabilities of 2.5 M as it is a great indicator of DNAPrint Genomics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining DNAPrint Genomics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DNAPrint Genomics is a good buy for the upcoming year.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. About DNAPrint Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in DNAPrint balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which DNAPrint's non-liquid assets can be easily converted into cash.
DNAPrint Genomics Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by DNAPrint Genomics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of DNAPrint Genomics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from DNAPrint Genomics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into DNAPrint Genomics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.At this time, DNAPrint Genomics' Change To Liabilities is most likely to increase significantly in the upcoming years. The DNAPrint Genomics' current Change To Inventory is estimated to increase to about 244.2 K, while Total Cash From Operating Activities is forecasted to increase to (4.9 M).
| 2010 | 2011 | 2024 | 2025 (projected) | Change To Netincome | 55K | 3.4M | 4.0M | 3.2M | Change To Liabilities | 22K | 2.0M | 2.3M | 2.5M |
DNAPrint Genomics cash flow statement Correlations
Click cells to compare fundamentals
DNAPrint Genomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
When determining whether DNAPrint Genomics is a strong investment it is important to analyze DNAPrint Genomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DNAPrint Genomics' future performance. For an informed investment choice regarding DNAPrint Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DNAPrint Genomics. If investors know DNAPrint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DNAPrint Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DNAPrint Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNAPrint Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNAPrint Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.